quadrivalent human papillomavirus vaccine + quadrivalent human papillomavirus vaccine
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Quadrivalent HPV Vaccine
Conditions
Quadrivalent HPV Vaccine, Human Papillomavirus Vaccine
Trial Timeline
Oct 1, 2010 → May 1, 2012
NCT ID
NCT01184079About quadrivalent human papillomavirus vaccine + quadrivalent human papillomavirus vaccine
quadrivalent human papillomavirus vaccine + quadrivalent human papillomavirus vaccine is a pre-clinical stage product being developed by Merck for Quadrivalent HPV Vaccine. The current trial status is completed. This product is registered under clinical trial identifier NCT01184079. Target conditions include Quadrivalent HPV Vaccine, Human Papillomavirus Vaccine.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01184079 | Pre-clinical | Completed |